Estrogen partial agonist that builds bone without uterine proliferation: Will accelerate its IND to file by the end of 1995; the previous target was 1996.

Ligand Pharmaceuticals Inc.

Read the full 36 word article

How to gain access

Continue reading with a
two-week free trial.